Table 4 |
|||||
|
Table summarizes chemotherapeutic regimen used to treat patients in the present study. |
|||||
|
Regimen |
Schedule |
Drugs and doses |
|||
|
|
|||||
|
EP |
On day 1 to 3, repeated after 21 days |
Etoposide 120 mg/m2 on day 1 to 3 |
Cisplatin 80 mg/m2, on day 1 |
||
|
MVAC |
On day 1, 2, 15, and 22, repeated after 28 days |
Methotrexate 30 mg/m2 on day 1, 15 and 22 |
Vimblastine 3 mg/m2 on day 2, 15, and 22 |
Doxorubicin 30 mg/m2 on day 2 |
Cispatin 70 mg/m2 on day 2 |
|
GC |
On day 1, 2, 8, and 15, repeated every 28 days |
Gemcitabine 1000 mg/m2 on day 1, 8 and 15 |
Cisplatin 70 mg/m2, on day 2 |
||
|
G |
On day 1, 8 and 15 repeated after 21 days |
Gemcitabine 1000 mg/m2 |
|||
|
|
|||||
|
EP = etoposide and cisplatin; MVAC = methotrexate, vimblastine, doxorubicin and cisplatin; GC = gemcitabine and cisplatin; G = gemcitabine |
|||||
|
Ismaili et al. BMC Urology 2009 9:4 doi:10.1186/1471-2490-9-4 |
|||||
